Skip to main content
Log in

Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Three children with hemolytic-uremic syndrome (HUS) were successfully treated with plasmapheresis (PP) combined with early hemodialysis and administration of Aspirin and dipyridamole. Stimulation of vascular prostacyclin release with patients' plasma was measured before and after PP. It was reduced before and increased after plasma exchange. The data indicate that PP might be a useful tool in treatment of (HUS) in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aronson EB, August CS (1975) Preliminary report: Treatment of the hemolytic-uremic syndrome with Aspirin and dipyridamole. J Pediatr 86:957

    Google Scholar 

  2. Appiani AC, Edefonti A, Bettinelli A, Cossu MM, Paracchini ML, Rossi E (1982) The relationship between plasma levels of the factor VIII complex and platelet release products (β-Thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome. Clin Nephrol 4:195–199

    Google Scholar 

  3. Beattie BJ, Murphy AV, Willoughby MLN, Belch JJF (1981) Prostacyclin Infusion in Hemolytic-Uremic Syndrome of Children. Br Med J 283:470–471

    Google Scholar 

  4. Beattie BJ, Murphy AV, Willoughby MLN, Machin SJ, Defreyn G (1981) Plasmapheresis in haemolytic-uraemic syndrome of children. Br Med J 282:6277

    Google Scholar 

  5. Bukowski RM, King JW, Hewlett JS (1977) Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 50:413–417

    Google Scholar 

  6. Byrnes JJ, Khurana M (1977) Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 297:1386–1389

    Google Scholar 

  7. Chamone DA, Proesmans WC, Monnens LA, Binda ki Muaka P, Vermylen JG (1982) Reversible deficient prostacyclin release in childhood hemolytic-uremic syndrome. Int J Ped Nephrol 1:13–16

    Google Scholar 

  8. Crain SM, Choudhury AM (1981) Thrombotic Thrombocytopenic Purpura. A Reappraisal. J Am Med Assoc 11:1243–1246

    Google Scholar 

  9. Defreyn G, Proesmans W, Machin SJ, Lemmens F, Vermylen J (1982) Abnormal prostacyclin metabolism in the hemolytic-uremic syndrome: equivocal effect of prostacyclin infusions. Clin Nephrol 18:43–49

    Google Scholar 

  10. Denneberg T, Friedberg M, Holmberg L (1981) Combined plasmapheresis (PP) and hemodialysis (HD) for severe hemolytic-uremic syndrome (HUS) — A new approach. Artif Organs 5A:13

    Google Scholar 

  11. Denneberg T, Friedberg M, Holmberg L, Mathiasen C, Nilsson KO, Takolander R, Walder M (1982) Combined plasmapheresis and hemodialysis treatment for severe hemolytic-uremic syndrome following Campylobacter colitis. Acta Paediatr Scand 71:243–245

    Google Scholar 

  12. Editorial (1979) Platelets, Endothelium, and Renal Disease. Lancet 11:890–891

  13. Gasser von C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) Hämolytisch-urämische Syndrome: Bilaterale Nierenrindennckrosen bei akuten erworbenen hämolytischen Anämien. Schweiz Med Wochenschr 85:905–909

    Google Scholar 

  14. Glöckner WM, Sieberth HG (1978) Plasmafiltration. A new method of plasma exchange. Proc Eur Soc Artif Organs 5:214–217

    Google Scholar 

  15. Hope W, Martin TJ, Chesterman CN, Morgan FJ (1979) Human beta-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells. Nature 288:210–212

    Google Scholar 

  16. Kaplan BS, Thomson PS, DeChadarévian JO (1976) The hemolytic-uremic syndrome. Pediatr Clin North Am 23:761–777

    Google Scholar 

  17. Machin SJ, Defreyn G, Chamone DAF, Vermylen J (1980) Plasma 6-Keto-PGF1 alpha levels after plasma exchange in the thrombotic thrombocytopenic purpura. Lancet 1:661

    Google Scholar 

  18. Moncada S, Vane JR (1978) Prostacyclin, platelet aggregation and thrombosis. In: De Gaetano S, Garattini S (eds) Platelets: A multidisciplinary approach. Raven Press, New York, pp 239–258

    Google Scholar 

  19. Pisciotta AV, Garthwaite T, Darin J, Aster RH (1977) Treatment of thrombotic thrombocytopenic purpura by exchange transfusion. Am J Hematol 3:73

    Google Scholar 

  20. Remuzzi G, Marchesi D, Mecca G, Misiani R, Livio M, De Gaetano G, Donati MB (1978) Hemolytic-uremic syndrome: Deficiency of plasma factor(s) regulating prostacyclin activity? Lancet 2:871–872

    Google Scholar 

  21. Remuzzi G, Misiani R, Marchesi D, Livio M, Mecca G, De Gaetano G, Donati MB (1979) Treatment of the hemolytic-uremic-syndrome with plasma. Clin Nephrol 12:279–284

    Google Scholar 

  22. Schrör K, Sauerland S, Kuhn A, Rösen R (1980) Different sensitivities of prostaglandin-cyclo-oxygenases in blood platelet and coronary arteries against non-steroidal anti-inflammatory drugs. Naunyn Schmiedeberg's Arch Pharmacol 313:69–73

    Google Scholar 

  23. Schrör K, Köhler P, Müller M, Peskar BA, Rösen P (1981) Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart. Am J Physiol 241:H18-H25

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gillor, A., Bulla, M., Roth, B. et al. Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children. Klin Wochenschr 61, 363–367 (1983). https://doi.org/10.1007/BF01485028

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01485028

Key words

Navigation